摘要 |
The invention relates to oligopeptides and derivatives thereof, to peptide analogs and derivatives thereof and to pharmaceutically acceptable salts of the compounds, which correspond to general formula (I), wherein: R<1> represents H, -C(O)-R<7>, -SO2-R<7>, -C(O)-OR<7> or -C(O)-N(R<7>)2; R<2> represents, independent of one another, H or -(C1-C4) alkyl; R<3> and R<6> represent, independent of one another, -(CH2)q-N(R<1>)R<8>; R<4> and R<5> represent, independent of one another, CH2-OR<2>, -CH(CH3)OR<8> or CH2-CH2-OR<8>; R<7> represents hydrogen, optionally substituted (C1-C19) alkyl, optionally substituted C1-C19 alkenyl, phenyl-C1-C4 alkyl whose phenyl radical is optionally substituted with amino in the p position; R<8> represents H, -(C1-C4) alkyl, -C(O)-R<7>, -C(O)-OR<7>, -C(O)-N(R<7>)2 or -SO2-R<7>; X represents oxygen (-O-) or -NH- or; XR<7>, with X = O, also represents the esters of alpha -tocopherol, tocotrienol or retinol or the carboxylic acid (with R<7> = H); m, n, p represent, independent of one another, zero or 1, and; q in R<3> and in R<6> represents, independent of one another, an integer from 1 to 4, with the provision that the following conditions do not simultaneously occur: R<4> = -CH (CH3) -OH and R<5> = -CH (CH3) -OH and R<6> = -(CH2)4-NH2. The invention also relates to dermopharmaceutically and cosmetically active compositions containing at least one compound of formula (I). |
申请人 |
PENTAPHARM AG;LUDIN, CHRISTIAN;HEIDL, MARC;ZIEGLER, HUGO |
发明人 |
LUDIN, CHRISTIAN;HEIDL, MARC;ZIEGLER, HUGO |